Negative Effects of Opioids on the Gastrointestinal Tract and The Development of Newer Therapeutics To Overcome Them

Viewing Options


Topic Information

Goal Statement

This activity has been designed to encourage the application of the latest advances in evidence-based medicine to achieve improved outcomes for the patients affected by OIC.

Target Audience

The on demand presentation will target gastroenterologists, physician assistants, and nurse practitioners involved in the management of patients suffering from OIC.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the burden and impact of OIC/OEC on patients and the healthcare system.

Effectively screen and diagnose patients with OIC/OEC.

Describe the evidence for use of novel therapies in the management of OIC/OEC and incorporate them effectively into practice.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Cincinnati and the GI Health Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: November 17th, 2017
Expiration Date: November 17th, 2018   
*This program has expired. CME credit is no longer available.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, GI Health Foundation staff and the University of Cincinnati staff have no relationships to disclose.

Darren Brenner- Speaker Consultant/Advisor: Ironwood/Allergan, Salix Pharmaceuticals, Shionogi, Synergy and Astra Zeneca/Daiichi Sankyo

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This activity is supported by an educational grant from Salix Pharmaceuticals.

Provided by:

Accredited by

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.